ARVO

Company

Also known as: ARVO

Related News

ARVO announces 2026 Advocacy Awards recipients

Apr 14, 2026

ARVO named Sangeetha Kandoi and Ellen Konadu Antwi-Adjei as the 2026 recipients of its annual Advocacy Awards. The honors recognize advocacy in eye and vision research and efforts to expand equitable access to care.

Opus Genetics Reports Progress in Gene Therapy Pipeline; Ultragenyx Announces Restructuring

Mar 10, 2026

Opus Genetics reported positive early data from its BEST1 gene therapy program and expects FDA action on its presbyopia treatment in October 2026. Ultragenyx announced 2025 revenue of $673 million and initiated a strategic restructuring plan targeting profitability in 2027.